BlogFebruary 15, 2024 Robin Arnott & Sandeep Prakash are Building Meditative States Through Sound – Podcast Episode #46
PressFebruary 15, 2024 MindBio Therapeutics Completes World First Take Home Phase 2a Microdosing Depression Trial
Market ResearchFebruary 14, 2024 Unveiling the Mysteries of the Mind: A Landmark Event in New Orleans
Market ResearchFebruary 12, 2024 A Doctor is Suing the DEA To Treat Terminally Ill Patients with Psilocybin
BlogFebruary 9, 2024 Rebecca Nicholson is Advancing the Field of Wellness for All – Podcast Episode #45
PressFebruary 9, 2024 PharmAla and Red Light Holland to Collaborate on Medical Psilocybin Development
PressFebruary 9, 2024 Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds
PressFebruary 7, 2024 Cybin Announces Grant of Two Additional Patents in Japan in Support of its DMT Program
PressFebruary 6, 2024 Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with BIRAD
PressFebruary 6, 2024 Clearmind Medicine Receives Patent Approval for its Psychedelic Based Treatment of Binge Behaviors in China
PressFebruary 2, 2024 Silo Pharma Announces Pipeline Prioritization for 2024 Targeting Mental Health, Chronic Pain, and Neurology
